PART I Overview Throughout our history, we have advanced the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is natures most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our immune medicine platform applies our proprietary technologies to read th...
Q2 FY2026 — expected 2026-08-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076902 | EDGAR | 86K words |
| 2025-03-03 | 2024-12-31 | 0000950170-25-030913 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0000950170-24-023095 | EDGAR | — |
| 2023-02-14 | 2022-12-31 | 0000950170-23-002792 | EDGAR | — |
| 2022-02-15 | 2021-12-31 | 0001564590-22-005228 | EDGAR | — |
| 2021-02-24 | 2020-12-31 | 0001564590-21-008124 | EDGAR | — |
| 2020-02-26 | 2019-12-31 | 0001564590-20-006830 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001193125-25-267061 | EDGAR | 28K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-103120 | EDGAR | — |
| 2025-05-01 | 2025-03-31 | 0000950170-25-061897 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123423 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0000950170-24-089342 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0000950170-24-054604 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062136 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0000950170-23-037234 | EDGAR | — |
| 2023-05-03 | 2023-03-31 | 0000950170-23-017250 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021923 | EDGAR | — |
| 2022-08-03 | 2022-06-30 | 0001564590-22-027784 | EDGAR | — |
| 2022-05-04 | 2022-03-31 | 0001564590-22-017870 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-05 | 0001193125-26-039409 | EDGAR | 4K words |
| 2026-01-12 | 0001193125-26-009840 | EDGAR | — |
| 2025-12-30 | 0001193125-25-335921 | EDGAR | — |
| 2025-11-05 | 0001193125-25-266974 | EDGAR | — |
| 2025-08-18 | 0001193125-25-182222 | EDGAR | — |
| 2025-08-05 | 0000950170-25-103058 | EDGAR | — |
| 2025-06-12 | 0001193125-25-140017 | EDGAR | — |
| 2025-05-01 | 0000950170-25-061851 | EDGAR | — |
| 2025-02-11 | 0000950170-25-017915 | EDGAR | — |
| 2024-11-07 | 0000950170-24-123369 | EDGAR | — |
107 total filings indexed. 78 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001478320 |
| Ticker | ADPT |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | WA |
| Website | https://www.adaptivebiotech.com |
| Listed | 2019-06-27 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report